
Sign up to save your podcasts
Or
Magic mushrooms, LSD and ketamine used to be associated with psychedelic trips and fun weekends. Now they’re increasingly viewed as serious medicine that can be used to treat ailments such as depression and PTSD. The small but fast-growing industry even has its first ETF — the Canadian-listed Horizons Psychedelic Stock ETF, or PSYK.
On this episode of Trillions, Eric and Joel speak with Steve Hawkins, the CEO of the firm behind the ETF, who was also behind the world’s first cannabis ETF. He talks the about sector outlook, underlying business fundamentals, the design of the ETF — and whether he plans to start micro-dosing LSD.
See omnystudio.com/listener for privacy information.
4.5
185185 ratings
Magic mushrooms, LSD and ketamine used to be associated with psychedelic trips and fun weekends. Now they’re increasingly viewed as serious medicine that can be used to treat ailments such as depression and PTSD. The small but fast-growing industry even has its first ETF — the Canadian-listed Horizons Psychedelic Stock ETF, or PSYK.
On this episode of Trillions, Eric and Joel speak with Steve Hawkins, the CEO of the firm behind the ETF, who was also behind the world’s first cannabis ETF. He talks the about sector outlook, underlying business fundamentals, the design of the ETF — and whether he plans to start micro-dosing LSD.
See omnystudio.com/listener for privacy information.
1,180 Listeners
405 Listeners
443 Listeners
2,161 Listeners
347 Listeners
1,795 Listeners
926 Listeners
965 Listeners
798 Listeners
2,003 Listeners
2,069 Listeners
65 Listeners
65 Listeners
31 Listeners
57 Listeners
403 Listeners
157 Listeners
4 Listeners
56 Listeners
2 Listeners
53 Listeners
7 Listeners
195 Listeners
12 Listeners
232 Listeners
19 Listeners
49 Listeners
83 Listeners
381 Listeners
48 Listeners